Literature DB >> 20483165

Negative symptoms and their predictors in schizophrenia within the Northern Finland 1966 Birth Cohort.

Jussi Mäkinen1, Jouko Miettunen, Erika Jääskeläinen, Juha Veijola, Matti Isohanni, Hannu Koponen.   

Abstract

Negative symptoms are a major scientific and therapeutic challenge in schizophrenia. We report the occurrence and predicting factors of negative symptoms at two time points in a population-based birth cohort. The negative symptoms of subjects with Diagnostic and Statistical Manual of Mental Disorders, third edition, revised (DSM-III-R) schizophrenia (n=46) were scrutinized at the first hospitalization due to psychosis from hospital records (first-episode psychosis) and with an interview approximately 10 years later (follow-up phase). Developmental and sociodemographic predictors of negative symptoms in first-episode psychosis, follow-up phase and at both measurements were analysed. Forty-one percent of the subjects had negative symptoms at the first episode, 39% in the follow-up phase, and in 24% the symptoms persisted at both measurements. Smoking at the age of 14, definite psychosocial stressor and not being married predicted more negative symptoms whereas good school performance and using less alcohol at age 14 predicted fewer persistent negative symptoms. These findings are new. However, we were not able to identify any major premorbid phenotype or endophenotype predicting negative symptoms which support the view that negative symptoms might mainly be a specific part of the illness.

Entities:  

Mesh:

Year:  2010        PMID: 20483165     DOI: 10.1016/j.psychres.2009.05.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Neural Responses to Smoking Cues in Schizophrenia.

Authors:  Lauren V Moran; Jennifer M Betts; Dost Ongur; Amy C Janes
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

Review 2.  Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review.

Authors:  Erika Jääskeläinen; Marianne Haapea; Nina Rautio; Pauliina Juola; Matti Penttilä; Tanja Nordström; Ina Rissanen; Anja Husa; Emmi Keskinen; Riikka Marttila; Svetlana Filatova; Tiina-Mari Paaso; Jenni Koivukangas; Kristiina Moilanen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Res Treatment       Date:  2015-05-18

Review 3.  Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options.

Authors:  Pierre Chue; Justine K Lalonde
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-08       Impact factor: 2.570

4.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

5.  Epidemiology and Treatment Guidelines of Negative Symptoms in Schizo-phrenia in Central and Eastern Europe: A Literature Review.

Authors:  Monika Szkultecka-Dębek; Jacek Walczak; Joanna Augustyńska; Katarzyna Miernik; Jarosław Stelmachowski; Izabela Pieniążek; Grzegorz Obrzut; Angelika Pogroszewska; Gabrijela Paulić; Marić Damir; Siniša Antolić; Rok Tavčar; Andra Indrikson; Kaire Aadamsoo; Slobodan Jankovic; Attila J Pulay; József Rimay; Márton Varga; Ivana Sulkova; Petra Veržun
Journal:  Clin Pract Epidemiol Ment Health       Date:  2015-09-23

6.  Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.

Authors:  Irina Rannikko; Graham K Murray; Pauliina Juola; Henri Salo; Marianne Haapea; Jouko Miettunen; Juha Veijola; Jennifer H Barnett; Anja P Husa; Peter B Jones; Marjo-Riitta Järvelin; Matti Isohanni; Erika Jääskeläinen
Journal:  Schizophr Res Cogn       Date:  2015-09-09

Review 7.  Health related quality of life in patients having schizophrenia negative symptoms - a systematic review.

Authors:  Chiraz Azaiez; Aurélie Millier; Christophe Lançon; Emilie Clay; Pascal Auquier; Pierre-Michel Llorca; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2018-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.